Finance

FDA grants breakthrough status to vTv’s diabetes drug By Investing.com

HIGH POINT, N.C. - vTv Therapeutics Inc . (NASDAQ:), a biopharmaceutical company, announced today that its diabetes treatment cadisegliatin has begun pivotal...

Morning Bid: Tech that – Nvidia slump sours market mood By Reuters

By Jamie McGeever (Reuters) - A look at the day ahead in Asian markets. The wave of profit-taking in U.S. Big Tech...

French feel even more deprived of vacation time than Americans do

Americans continue to lead the world when it comes to prioritizing work over vacation: 53% don’t plan on using all of their time...

Oracle warns that a TikTok ban would hurt business

Oracle CEO Safra Catz, center, departs following a meeting on Capitol Hill in Washington on June 18, 2024. Chief executives from major companies...

Interpublic Outperforms the Industry, Winning 10 Grand Prix and 1 Titanium at the Cannes Lions International Festival of Creativity By Investing.com

IPG Awarded More of the Festival's Highest Honors than Any CompanyIPG PR Agencies Dominate, Winning Three Grand Prix IPG's Three Global Creative Networks...

Robbins LLP Reminds The Scotts Miracle-Gro Company Stockholders about the Class Action Lawsuit Filed Against SMG By Investing.com

SAN DIEGO, June 24, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons...

Atlassian’s president sells shares worth $121,600 By Investing.com

Atlassian Corp (NASDAQ:) President Anutthara Bharadwaj sold a total of 760 shares of the company's Class A Common Stock for an average price...

Clip Money Inc. Announces Results of Voting at Annual and Special Meeting of Shareholders By Investing.com

TORONTO, June 24, 2024 (GLOBE NEWSWIRE) -- Clip Money, Inc. (Clip or Company) (TSXV:CLIP) (OTCQB:CLPMF), a company that operates a multi-bank self-service deposit...

Century Therapeutics shareholders elect directors, ratify accountant By Investing.com

In a recent 8-K filing with the Securities and Exchange Commission (SEC), Century Therapeutics, Inc. disclosed the outcomes of its 2024 Annual Meeting...

Latest articles

spot_imgspot_img